Flecainide

5 trials 4 recruiting CCardiology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

4 Recruiting

1 Completed trials

4 Sponsors

4 Countries

Phase III

Phase III/IV

Phase IV

Phase III: 2 Phase III/IV: 1 Phase IV: 2

Oversight events:

2 serious breaches across 1 trial

View oversight register →

Indications tested

Mitral valve prolapse 1 Ventricular extrasystoles 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 2 Amsterdam UMC 1 Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela 1 Oslo University Hospital HF 1

All trials

5 total

Optimal drug therapy for the suppression of ventricular arrhythmias in Andersen-Tawil syndrome and multifocal ectopic Purkinje-related prema… Recruiting

2024-510682-42-01 Phase IV 1 country Amsterdam UMC
SUPPRESS. Prophylactic frequent premature ventricular complexeS sUPPression on left ventriculaR function impairmEnt in aSymptomatic patientS Recruiting

2024-516372-14-00 Phase III/IV 1 country Assistance Publique Hopitaux De Paris
Carvedilol vs. flecainida clinical trial in idiopathic ventricular arrhythmias. Recruiting

2023-510362-26-00 Phase IV 1 country Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela
Effect and safety of flecainide and metoprolol alene to suppress ventricular arrhythmias in arrhythmic mitral valve prolapse. Recruiting

2022-500814-24-00 Phase III 1 country Oslo University Hospital Hf
Assessment of Flecainide to Lower the patent foramen Ovale closure risk of Atrial arrhythmia or Tachycardia Ended

2024-513324-42-00 Phase III 1 country Assistance Publique Hopitaux De Paris

Showing 1–5 of 5 trials

← All drugs A–Z